21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Use of adenosine Areceptor agonists for treatment of neuropathic pain
#4802Quadruple therapy useful for treating persons afflicted with the human immunodeficiency virus (HIV)
#4803HDAC 6 inhibitor-based methods for treating cancer
#4804Compositions and methods for reducing or preventing obesity
#4805INTESTINE AND MUSCLE RECOVERY
#4806Rapid opioid detoxification
#4807FORMULATION FOR HGH AND RHIGF-1 COMBINATION
#4808Compositions and methods of treatment that include plant extracts
#4809Compositions and method for enhancing insulin activity
#4810Preparation comprising amino acids and plants and its activity in the alcohol detoxification
#4811Treatment of suicidal ideation or behavior using inhibitors of nicotinic acetylcholine receptors
#4812NOVEL MANNOPYRANOSIDE DERIVATIVES WITH ANTICANCER ACTIVITY
#4813Thiazole Compounds, and Compositions and Methods Using Same
#4814Methods and Compounds Useful to Induce Apoptosis in Cancer Cells
#4815Method for oxygen treatment of intact skin
#4816COMPOSITIONS AND METHODS OF TREATING PULMONARY HYPERTENSION
#4817Pomegranate fruit polyphenol composition and methods of use and manufacture thereof
#4818MicroRNA-140-5p as a tumor suppressor and sensitizing agent for chemotherapy
#4819Purified amniotic membrane compositions and methods of use
#4820Compositions for topical application comprising a peroxide and retinoid
#4821Colon vitamin
#4822Compositions and methods for nutritional supplementation
#4823METHODS OF TREATING CENTRAL NERVOUS SYSTEM TUMORS
#4824TREATMENT OF BREAST CANCER WITH IODONITROBENZAMIDES IN COMBINATION WITH ANTI-TUMOR AGENTS
#4825Ophthalmic composition containing xanthan gum and amino acid
#4826Compositions and Methods for Treatment of Ovarian, Peritoneal, and Fallopian Tube Cancer
#4827Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor
#4828Anti-neoplastic compositions comprising extracts of black cohosh
#4829Nutraceutical composition that comprises extract of andean shilajit, for preventing and/or treating neurodegenerative diseases and/or the cognitive deterioration associated with cerebral aging
#4830PHYTOESTROGENIC FORMULATIONS FOR ALLEVIATION OR PREVENTION OF HAIR LOSS
#4831Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors
#4832USE OF PLANT EXTRACTS AS PREBIOTICS, COMPOSITIONS AND FOODS CONTAINING SUCH EXTRACT
#4833Compositions and soft tissue replacement methods
#4834ALLOGENEIC STEM CELL TRANSPLANTS IN NON-CONDITIONED RECIPIENTS
#4835Stable Preserved Compositions of Interferon-Beta
#4836Hepatitis C Inhibitor Compounds
#4837Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
#4838Compositions and methods for reducing the risk of preterm labor
#4839Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent
#4840T TYPE CALCIUM CHANNEL BLOCKERS AND THE TREATMENT OF DISEASES
#4841COMBINATION THERAPY WITH PARP INHIBITORS
#4842Respiratory disease treatment
#4843Methods for the treatment of CNS-related conditions
#4844Compositions for the treatment of CNS-related conditions
#4845METHOD FOR THE TREATMENT, ALLEVIATION OF SYMPTOMS OF, RELIEVING, IMPROVING AND PREVENTING A COGNITIVE DISEASE, DISORDER OR CONDITION
#4846Antihypertensive pharmaceutical composition
#4847Stable pharmaceutical composition of freeze-dried tetrodotoxin powder
#4848Composition and method for treating hemorrhoids and/or anorectal disorders
#4849PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREVENTING, TREATING, OR REVERSING NEURONAL DYSFUNCTION
#4850Heterocyclic modulators of lipid synthesis
#4851Methods of sensitizing drug resistant microorganisms using methylsulfonylmethane (MSM)
#4852Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
#4853Method for treatment of macular degeneration by modulating P2Y12 or P2X7 receptors
#4854BETA-L-2'-DEOXY-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B
#4855ANTIMICROBIAL COMPOSITIONS COMPRISING 15-HETRE AND METHODS OF USE THEREOF
#4856Methods And Compositions For The Treatment Of Anxiety Disorders, Including Post Traumatic Stress Disorder (PTSD) And Related Central Nervous System (CNS) Disorders.
#4857Uses of hypoxia-inducible factor inhibitors
#4858COMPOSITION COMPRISING TORASEMIDE
#4859Co-administration of FGF-21 and GLP-1 to treat diabetes and lower blood glucose
#4860BUFFERED OPHTHALMIC COMPOSITIONS AND METHODS OF USE THEREOF
#4861METHODS OF USING [3.2.0] HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF FOR TREATING INFECTIOUS DISEASES
#4862Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients
#4863Decellularized and Delipidized Extracellular Matrix and Methods of Use
#4864Nutritional Supplement Comprising Nut and Seed Oil Composition
#4865Bioavailability enhancing composition
#4866Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular Permeability
#4867Body Aqua
#4868Dual drug dosage forms with improved separation of drugs
#4869Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#4870Methods and compositions for treating HIV infection
#4871Formulations
#4872COMPOSITIONS AND METHODS FOR INHIBITING AND/OR MODULATING EFFECTOR T-CELLS INVOLVED IN INFLAMMATORY NEURODEGENERATIVE DISEASE
#4873STABILISED PARTICLES COMPRISING 5-METHYL-(6S)-TETRAHYDROFOLATE
#4874Methods for inhibiting allograft rejection
#4875CD40 ANTIBODY FORMULATION AND METHODS
#4876Methods of treatment with DLL4 antagonists and an anti-hypertensive agent
#4877METHOD OF TREATING CANCERS AND A PHARMACEUTICAL COMPOSITION THAT MAY BE USED IN PRACTICING SAID METHOD
#4878Combination therapy of an afucosylated CD20 antibody with fludarabine and/or mitoxantrone
#4879Managing and treating keloids
#4880Treatment of neurodegenerative disease
#4881Indirect Substrates for Microorganisms Metabolizing 1,2-Propanediol
#4882Compositions and methods for soft tissue replacement
#4883Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
#4884Combinations Comprising Heterocyclic Inhibitors of MEK and Methods of Use Thereof
#48851′-substituted pyrimidine N-nucleoside analogs for antiviral treatment
#4886Compositions and methods for reducing the risk of preeclampsia
#4887Composition and method for modulating and maintaining vaginal bacterial flora and vaginal acidity
#4888Topical skin care composition
#4889Promoting Whole Body Health
#4890Natural polypeptides for oral health care
#4891COMBINATION OF MEDICAMENTS FOR THE TREATMENT OF RESPIRATORY DISEASES
#4892Treatment and diagnosis of inflammatory disorders and HIV
#4893Compositions Containing Zinc Salts for Coating Medical Articles
#4894Photodynamic therapy for tumors with localized delivery
#4895Treatment of hypoxic tumors with localized oxygenation
#4896Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
#4897Topical retinoid solutions
#4898Treatment for Amyotrophic Lateral Sclerosis
#4899ANTICOAGULANT COMPOUNDS AND THEIR USE
#4900Preparation and Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane In The Treatment of Conditions Affected by Monoamine Neurotransmitters
#4901METHOD OF TREATING A CANCER BY ADMINISTERING A SPECIFIED DRUG
#4902Therapeutic or prophylactic agent for diabetes
#49035-HTP COMBINATION THERAPY
#4904Process for the synthesis of quaternary amine compounds
#4905Antibacterial Agent for Drug-Resistant Bacteria, Method for Screening for Same, and Use of Same
#4906USE OF A2B ADENOSINE RECEPTOR ANTAGONISTS FOR TREATING HEART FAILURE AND ARRHYTHMIA IN POST-MYOCARDIAL INFARCTION PATIENTS
#4907Composition and Methods for Treating Hair Loss
#4908Compositions and methods for the treatment of drug-induced hand-foot syndrome
#4909Association Between Ferroquine and an Artemisinine Derivative for Treating Malaria
#4910METHOD FOR TREATING HAEMATOLOGICAL CANCERS
#4911Targeting Estrogen Receptors in the Treatment of Lymphangioleiomyomatosis
#4912COMBINATION
#4913COMBINATION OF POLYCHITOSAMINE AND HMG-COA REDUCTASE INHIBITOR FOR HYPERLIPIDEMIA
#4914Of gastrointestinal health, immunity and performance by dietary intervention
#4915SYNERGISTIC INHIBITION OF LOW-DENSITY LIPOPROTEIN OXIDATION
#4916Polypeptoid pulmonary surfactants
#4917Glucopyranoside compound
#4918DRUG RESISTANT IMMUNOTHERAPY FOR TREATMENT OF A CANCER
#4919Methods for inducing a natural killer (NK) cell-mediated immune response and for increasing NK cell activity
#4920Thickener composition for dysphagia patients
#4921Synergistic compositions and methods
#4922Anticancer combination of artemisinin-based drugs and other chemotherapeutic agents
#4923PARP INHIBITORS FOR THE TREATMENT OF CIPN
#4924Methods for Treating Bacterial Infection
#4925Functionally-coated multilayer tablets
#4926Compositions For The Treatment of Central Nervous System Disorders Including Depression Employing Novel Drug Combination Therapy To Reduce Suicidality In Patients
#4927METHODS AND COMPOSITIONS TO PROMOTE OCULAR HEALTH
#4928Methods and compositions for the treatment of influenza
#4929METHOD FOR INHIBITING ANGIOGENESIS
#4930Immunogenic anti-inflammatory compositions
#4931Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
#4932Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibodies
#4933COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
#4934Inhibitors of guanine exchange factors and their use as anticancer drugs
#4935Method of treating rheumatoid arthritis with an anti-IL-6R antibody
#4936PLATELET SOLUTION FOR USE IN JOINT SURGERY
#4937IMMUNOTHERAPY
#4938Methods and compositions for promoting organ development
#4939Use of 2,3-dihydroxypropyl dodecanoate for treating seborrhoea
#4940Oral hygiene method and formula
#4941USES OF APOPTOTIC CELL-TARGETING PEPTIDES, LABEL SUBSTANCES AND LIPOSOMES CONTAINING A THERAPEUTIC AGENT FOR PREVENTING, TREATING OR THERAPEUTICALLY DIAGNOSING APOPTOSIS-RELATED DISEASES
#4942Bepotastine compositions
#4943Composition for solubilizing tissue and cells comprising N-tetradecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate and polyoxyethylene (10) cetyl ether
#4944STEM CELL TARGETING
#4945Combination composition comprising benzoyl peroxide and adapalene
#4946Compositions and Methods for Treating Neurologic Disorders
#4947COMPOSITION AND METHOD FOR TREATING DIABETES AND METABOLIC DISORDERS
#4948CATECHINS FOR THE TREATMENT OF AMYLOIDOSIS
#4949Positive allosteric modulators of nicotinic acetylcholine receptor
#4950Sustained-release product comprising a combination of a non-opioid amine and a non-steroidal anti-inflammatory drug
#4951ABUSE-RESISTANT CONTROLLED-RELEASE OPIOID DOSAGE FORM
#4952TIVOZANIB AND CAPECITABINE COMBINATION THERAPY
#4953COMBINATION OF THERAPY COMPRISING ZD6474 AND A TAXANE
#4954Combination Therapy
#4955Drug Combinations and Uses in Treating a Coughing Condition
#4956Inhibitors of bruton'S tyrosine kinase
#4957Inhibitors of Bruton's tyrosine kinase
#4958METHODS OF TREATING FUNGAL INFECTIONS
#4959Use of phosphodiesterase inhibitors for treating multidrug resistance
#4960COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER
#4961ANALGESIC COMBINATION OF OPIOID ANALGESIC AND CYCLOOXYGENASE-2 INHIBITOR
#4962Method for diagnosing, preventing, and treating neurological diseases
#49632-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations
#4964COMPOSITION CONTAINING PROTOPANAXATRIOL AND PROTOPANAXADIOL
#4965Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
#4966USE OF IRBESARTAN FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION OF HOSPITALIZATION FOR HEART FAILURE
#4967Anti-cancer agent
#4968Pharmaceutical Compositions and Methods for Treating, Controlling, Ameliorating, or Reversing Conditions of the Eye
#4969Therapeutic target for pancreatic cancer cells
#4970Compositions, methods and kits for repressing virulence in gram positive bacteria
#4971Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections
#4972FORMULATIONS FOR REDUCING NEURONAL DEGENERATION
#4973Use of GLUT4 inhibitors and DNA damaging agents for treating multiple myeloma
#4974Methods involving PDGFRBETA inhibitors
#4975Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
#4976PTH-CONTAINING THERAPEUTIC/PROPHYLACTIC AGENT FOR OSTEOPOROSIS, CHARACTERIZED IN THAT PTH IS ADMINISTERED ONCE A WEEK IN A UNIT DOSE OF 100 TO 200 UNITS
#4977Val (8) GLP-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome
#4978Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
#4979INSULIN PREPARATIONS CONTAINING METHIONINE
#4980Regulating the Amino Acid Pool Used for the Acute-Phase Protein Synthesis
#4981Heat resistant bioactive composition
#4982ANTI-DIABETIC EXTRACT OF HONEYBUSH
#4983Mole Eliminating Ointment
#4984Nutritional Supplement Comprising Nut Oil Composition
#4985Traditional Chinese drug comprising Danshen extracts and Sanqi extracts and use thereof
#4986Amino acid composition with improved dispersibility
#4987Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefrom
#4988Methods of treating or preventing peritonitis with oxidative reductive potential water solution
#4989REMISSION THERAPY OF CANCER WITH ISOFLAVONOIDS
#4990COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER
#4991Process for manufacturing biocompatible material
#4992MicroRNA-29a,b,c as a Tumor Suppressor and Sensitizing Agent for Chemotherapy
#4993AGENT FOR INTRA-ARTICULAR INJECTION
#4994CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS
#4995COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF
#4996Endopeptidase and Neurotoxin Combination Treatment of Multiple Medical Conditions
#4997Combination immunotherapy for the treatment of cancer
#4998ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)
#4999COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS
#5000COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
#5001COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
#5002COMBINATION THERAPY OF HER EXPRESSING TUMORS
#5003Non-Human Mammal Model Of Human Hematopoietic Cancer
#5004Super fast-acting insulin compositions
#5005Pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent
#5006COMPOSITION AND PRODUCTS FOR ENABLING THE PRODUCTION OF EQUOL IN VIVO
#5007Inhibitors of hepatitis C virus
#5008EZATIOSTAT FOR TREATING MULTIPLE MYELOMA
#5009PTERIN BASED THERAPIES FOR INFLAMMATORY CONDITIONS
#5010Compositions And Methods For Immunotherapy
#5011USE OF TRUNCATED CYSTEINE IL28 AND IL29 MUTANTS TO TREAT CANCERS AND AUTOIMMUNE DISORDERS
#5012Antibody targeting osteoclast-related protein Siglec-15
#5013Infarction treatment compositions and methods
#5014Method for treatment of a glomerular disease comprising administration of anion exchange resin
#5015Chalcones as enhancer of antimicrobial agents
#5016Methods and compositions for modulating adipocyte function
#5017Treatment of liver disorders by administration of RAP conjugates
#5018Adjuvant immunotherapy for the preventive, curative or palliative treatment of chronic systemic diseases such as cancer, of clinical manifestations associated with diseases like cachexia and correction of adverse effects of drugs such as immunosuppression, neutropenia and lymphopenia, comprising the association or combination of a biological response modifier specially selected and other substances with antineoplastic action and/or other treatments
#5019Polymer composite, water-treatment method using the same and manufacturing method of the same
#5020Combination Therapy
#5021Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
#5022PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF BLADDER DISORDERS
#5023Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease
#5024Pharmaceutical compositions having desirable bioavailability
#5025CANNABINOIDS FOR USE IN THE TREATMENT OF NEUROPATHIC PAIN
#5026COMPOSITIONS AND METHODS FOR INHIBITING HAIR GROWTH
#5027METHODS AND PRODUCTS FOR TREATING INFLAMMATION
#50281,8-naphthyridine compounds for the treatment of cancer
#5029PHARMACEUTICAL COMPOSITION CONTAINING TOSUFLOXACIN OR SALT THEREOF
#5030AUTOPHAGY INDUCING COMPOUND AND THE USES THEREOF
#5031Heterobicyclic carboxamides as inhibitors for kinases
#5032COMBINATION CANCER THERAPY WITH HSP90 INHIBITORY COMPOUNDS
#5033Bisfluoroalkyl-1,4-benzodiazepinone compounds
#5034ANDROGEN PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DEPRESSION
#5035Composition comprising benzoic acid in combination with organic acid preservatives as active ingredients and the use thereof
#50366-substituted estradiol derivatives for use in remyelination of nerve axons
#5037METHODS OF TREATING SQUAMOUS CELL LUNG CANCER WITH 4-IODO-3-NITROBENZAMIDE IN COMBINATION WITH GEMCITABINE AND CARBOPLATIN
#50381-methylnicotinaide derivatives and formulations of treatment of lipoprotein abnormalities
#5039COMPOSITIONS COMPRISING IGF1 AGONISTS AND USES THEREOF
#5040MINERAL SALT-SULFONIC ACID COMPOSITIONS AND METHODS OF USE
#5041MEANS AND METHODS FOR TREATING ISCHEMIC CONDITIONS
#5042Composition having lipolysis-promoting effect
#5043Compositions for alleviating inflammation and oxidative stress in a mammal
#5044COMPOSITIONS AND METHODS FOR NUTRITION SUPPLEMENTATION
#5045BIOLOGICALLY ACTIVE FOOD ADDITIVE FOR THE PROPHYLAXIS OF OSTEOPOROSIS DISEASE
#5046TREATMENT COMPOSITION AND METHOD
#5047EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF
#5048Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitor
#5049ENHANCED METHOD AND COMPOSITION FOR THE TREATMENT OF HIV+ TUBERCULOSIS PATIENTS WITH ANTI-RETROVIRAL DRUGS AND LIPOSOMAL ENCAPSULATION FOR DELIVERY OF REDUCED GLUTATHIONE
#5050Compositions and methods for treatment of the side-effects associated with administration of cancer chemotherapeutic agents
#5051PHARMACEUTICAL COMPOSITION CONTAINING MEDICAMENT-CONTAINING FINE PARTICLES AND METHOD FOR PRODUCING SAME
#5052COMPOSITIONS AND METHODS FOR CONTROLLING DISEASES IN ANIMALS
#5053USE OF TRYPTANTHRIN COMPOUNDS FOR IMMUNE POTENTIATION
#5054Treatment for Radiation-Induced Disorders
#5055METHODS OF TREATING AMYLOIDOSIS COMPRISING THE USE OF ANTI-AMYLOID BETA ANTIBODIES
#5056DOSAGE REGIMEN FOR ADMINISTERING AN EpCAMxCD3 BISPECIFIC ANTIBODY
#5057USE OF TNF-ALPHA INHIBITORS FOR TREATING A NERVE DISORDER MEDIATED BY NUCLEUS PULPOSUS
#5058ENHANCED IMMUNOLOGICAL RESPONSES
#5059ANTIDOTES FOR NITROBENZODIAZEPINES
#5060Use Of Anogeissus Extract For Fibrillin Production In Skin
#5061Cell preparation for erectile dysfunction or sensory disorders of the lower urinary tract containing adipose tissue derived mesenchymal stem cells
#5062Perivascular stem cell composition for bone
#5063Peptides for the Treatment of HCV Infections
#5064INHIBITORS OF HEMOPOIETIC CELL KINASE (P59-HCK) AND THEIR USE IN THE TREATMENT OF INFLUENZA INFECTION
#5065Anti-infective agents and uses thereof
#5066Method of immunotherapy for treament of human papillomavirus infection
#5067METHOD OF TREATMENT OF PHILADELPHIA CHROMOSOME POSITIVE LEUKAEMIA
#5068IMMUNOGENIC COMPOSITION AND METHODS
#5069Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis
#5070USE OF THE COMBINATION OF TERIFLUNOMIDE AND GLATIRAMER ACETATE FOR TREATING MULTIPLE SCLEROSIS
#5071Reversely thermo-reversible hydrogel compositions
#5072ORAL COMPOSITIONS CONTAINING A COMBINATION OF NATURAL EXTRACTS AND RELATED METHODS
#5073ORAL COMPOSITIONS CONTAINING EXTRACTS OF ZINGIBER OFFICINALE AND RELATED METHODS
#5074ORAL COMPOSITIONS CONTAINING EXTRACTS OF MYRISTICA FRAGRANS AND RELATED METHODS
#5075HEAT- AND VIBRATION-STABLE INSULIN PREPARATIONS
#5076CYCLOOXYGENASE INHIBITOR AND CALCIUM CHANNEL ANTAGONIST COMPOSITIONS AND METHODS FOR USE IN UROLOGICAL PROCEDURES
#5077Pharmaceutical composition comprising propofol
#5078MODULATORS OF RETINOL-RETINOL BINDING PROTEIN (RBP)-TRANSTHYRETIN (TTR) COMPLEX FORMATION
#5079Formulations for the treatment of pain
#5080Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
#5081Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine
#5082ACYCLOVIR FORMULATIONS
#50835-HT1A receptor subtype agonist
#5084Triazine Derivatives and their Therapeutical Applications
#5085TREATMENT OF CANCER BY TARGETING MOLECULES THAT INFLUENCE MST1/STK4 SIGNALING
#5086TREATMENT OF HUMAN OSTEOSARCOMA
#5087Granulated anthelmintic preparations and delivery systems
#50882-DEOXY-D-GLUCOSE FORMULATIONS FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASES
#5089Agent for the treatment of alopecia
#5090Cellular factor-containing solution compositions
#5091Methods for reducing GnRH-positive tumor cell proliferation using the GnRH antagonist IN3
#5092Pharmaceutical composition for treating cutaneous burns
#5093Profiles of lipid proteins and inhibiting HMG-CoA reductase
#5094Formulations, devices and methods for treating and preventing mucositis
#5095Stabilized hypohalous acid solutions
#5096PEPTIDE ABLE TO DISRUPT THE PROTEIN COMPLEX BETWEEN THE HIS273 MUTADED P53 PROTEIN AND THE ONCOSUPPRESSIVE P73 PROTEIN IN TUMOR CELLS AND THERAPEUTIC USES THEREOF
#5097INJECTABLE COMPOSITIONS FOR INTRA-ARTICULAR USE COMBINING A VISCOSUPPLEMENTATION AGENT AND A FIBROBLAST GROWTH MEDIUM
#5098ABUSE-RESISTANT OPIOID DOSAGE FORM
#5099MULTILAYER PHARMACEUTICAL COMPOSITION THAT CAN BE DISPERSED IN WATER AND WHICH CONTAINS A COMBINATION OF ANTIMALARIAL AGENTS
#5100Anti-constipation composition